Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial.
- DOI
- 10.1136/rmdopen-2025-006094
- Published
- 2026 Jan 30
- Container
- RMD open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/rmdopen-2025-006094,
title = {Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial.},
author = {Smolen JS and Mikuls TR and Galloway J and Müller-Ladner U and Curtis JR and Hashimoto M and Takeuchi T and Choy E and Tanaka Y and Cara C and Lauwerys B and Tilt N and Ufuktepe B and Taylor PC},
year = {2026},
journal = {RMD open},
doi = {10.1136/rmdopen-2025-006094},
url = {https://doi.org/10.1136/rmdopen-2025-006094}
}RIS
TY - JOUR TI - Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial. AU - Smolen JS AU - Mikuls TR AU - Galloway J AU - Müller-Ladner U AU - Curtis JR AU - Hashimoto M AU - Takeuchi T AU - Choy E AU - Tanaka Y AU - Cara C AU - Lauwerys B AU - Tilt N AU - Ufuktepe B AU - Taylor PC PY - 2026 JO - RMD open DO - 10.1136/rmdopen-2025-006094 UR - https://doi.org/10.1136/rmdopen-2025-006094 ER -
APA
JS, S., TR, M., J, G., U, M., JR, C., M, H., T, T., E, C., Y, T., C, C., B, L., N, T., B, U., & PC, T. (2026). Do high rheumatoid factor levels impact response to certolizumab pegol in patients with inadequately controlled rheumatoid arthritis? A post hoc analysis of the phase IIIb REALISTIC trial.. RMD open. https://doi.org/10.1136/rmdopen-2025-006094
Source records
- pubmed · retrieved 2026-09-26T03:21:58.237Z